Expanded clinical and experimental use of SOX11 - using a monoclonal antibody

[1]  M. Dictor,et al.  Expanded clinical and experimental use of SOX11 - using a monoclonal antibody , 2012, BMC Cancer.

[2]  Jian-yong Li,et al.  The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases , 2012, Medical Oncology.

[3]  K. Fu,et al.  Cyclin D1-negative Blastoid Mantle Cell Lymphoma Identified by SOX11 Expression , 2012, The American journal of surgical pathology.

[4]  C. Borrebaeck,et al.  Knock‐down of SOX11 induces autotaxin‐dependent increase in proliferation in vitro and more aggressive tumors in vivo , 2011, Molecular oncology.

[5]  Sandra Sernbo,et al.  The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation , 2011, BMC Cancer.

[6]  R. Lai,et al.  Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis , 2011, Haematologica.

[7]  Elin Gustavsson,et al.  SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies , 2010, Molecular Cancer.

[8]  A. Rosenwald,et al.  Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. , 2010, Cancer research.

[9]  Elin Gustavsson,et al.  Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt’s lymphoma , 2009, Haematologica.

[10]  L. Staudt,et al.  SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype , 2009, Haematologica.

[11]  M. Covic,et al.  Expression of Sox11 in adult neurogenic niches suggests a stage‐specific role in adult neurogenesis , 2009, The European journal of neuroscience.

[12]  Sami Kilpinen,et al.  The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer. , 2009, European journal of cancer.

[13]  A. Bahnassy,et al.  Flow cytometric immunophenotyping (FCI) of lymphoma: correlation with histopathology and immunohistochemistry , 2008, Diagnostic pathology.

[14]  B. Sander,et al.  The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival , 2008, British journal of haematology.

[15]  W. Klapper,et al.  Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations , 2008, Haematologica.

[16]  Karin Jirström,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only. , 2006 .

[17]  Clive R Taylor,et al.  Recommendations for Improved Standardization of Immunohistochemistry , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[18]  T. Perlmann,et al.  The establishment of neuronal properties is controlled by Sox4 and Sox11. , 2006, Genes & development.

[19]  C. Milstein,et al.  Pillars Article: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 1975, 256 (5517): 495–497. , 2005 .

[20]  Ernst R. Tamm,et al.  Gene Targeting Reveals a Widespread Role for the High-Mobility-Group Transcription Factor Sox11 in Tissue Remodeling , 2004, Molecular and Cellular Biology.

[21]  R. Braylan,et al.  Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[22]  F. Pontén,et al.  Affinity Proteomics for Systematic Protein Profiling of Chromosome 21 Gene Products in Human Tissues* , 2003, Molecular & Cellular Proteomics.

[23]  D. Catovsky,et al.  Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry , 2002, Journal of clinical pathology.

[24]  D. Catovsky,et al.  Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. , 2001, Leukemia research.

[25]  E. Hsi.  A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory. , 2001, Archives of pathology & laboratory medicine.

[26]  M. Wegner,et al.  From head to toes: the multiple facets of Sox proteins. , 1999, Nucleic acids research.

[27]  P. Koopman,et al.  Expression of the Sox11 gene in mouse embryos suggests roles in neuronal maturation and epithelio‐mesenchymal induction , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[28]  J. Hardelin,et al.  The human SOX11 gene: cloning, chromosomal assignment and tissue expression. , 1995, Genomics.

[29]  H. Clevers,et al.  Sox‐4, an Sry‐like HMG box protein, is a transcriptional activator in lymphocytes. , 1993, The EMBO journal.

[30]  B. Nathwani,et al.  Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia , 1982, Cancer.

[31]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[32]  Taketo Yamada.  Therapeutic monoclonal antibodies. , 2011, The Keio journal of medicine.

[33]  L. Peterson,et al.  Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms , 2010, Modern Pathology.

[34]  Valsamo Anagnostou,et al.  Antibody validation. , 2010, BioTechniques.

[35]  Gabriele Schackert,et al.  Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. , 2005, Oncology reports.

[36]  Y. Masuho,et al.  Human SOX11, an upregulated gene during the neural differentiation, has a long 3' untranslated region. , 1999, DNA research : an international journal for rapid publication of reports on genes and genomes.